Alnylam Pharmaceuticals
ALNY
#733
Rank
ยฃ25.95 B
Marketcap
ยฃ193.99
Share price
-1.76%
Change (1 day)
-41.67%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company